Objective: Current guidelines recommend that carotid endarterectomy (CEA) be performed as early as possible after the neurologic index event in patients with 50% to 99% carotid artery stenosis. However, recent registry data showed that patients treated #48 hours had a significantly increased perioperative risk. Therefore, the aim of this single-center study was to determine the effect of the time interval between the neurologic index event and CEA on the periprocedural complication rate at our institution.
Of all ischemic strokes, 10% to 15% are related to an extracranial internal carotid artery (ICA) stenosis or occlusion. 1 According to a very recent review, the stroke risk is as high as 6.4% (1.5%-23.8%) within the first 2 to 3 days, 19 .5% (12.7%-28.7%) #7 days, and 26.1% (20.6%-32.5%) #14 days after an ischemic carotid-related neurologic event caused by ICA stenosis. 2 Meta-analyses of large multicenter randomized controlled trials (RCTs) of best medical treatment alone compared with carotid endarterectomy (CEA) plus best medical treatment have revealed that CEA of 50% of 99% ICA stenosis was highly effective in stroke prevention. The primary end point in these studies was the risk of any stroke or mortality #30 days or ipsilateral ischemic strokes up to 5 years after surgery. The absolute risk reduction achieved by surgery in individuals with $50% stenosis was 18.5%, 9.8%, 5.5%, or 0.8% if randomization for surgery was performed #14 days, 2 to 4 weeks, 4 to 12 weeks, or thereafter, respectively. 3 The median delay between randomization and surgery was 7 days. 4 These subgroup analyses led to strong recommendations for performing CEA as early as possible (#2 weeks) in patients with 50% to 99% (North American Symptomatic Carotid Endarterectomy Trial [NASCET]) symptomatic carotid stenosis in almost all current national and international guidelines. [5] [6] [7] However, there are still concerns that early CEA within the first days after the index event might be associated with an increased stroke and mortality rate: a recent Author conflict of interest: none.
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Copyright Swedish register study showed that patients treated #48 hours had a significantly increased perioperative mortality and stroke risk (12% #48 hours vs 4% between 3 and 7 days; P < .001). 8 Another retrospective study compared patients who underwent CEA within the first 4 weeks after the most recent neurologic event (early CEA) with those who were treated later (delayed CEA). The risk of perioperative stroke was significantly increased in patients undergoing early CEA compared with those who were treated later (5.1% vs 1.6%; P ¼ .002). 9 Because CEA in these patients is performed as soon as possible at our institution, the current study aimed to clarify whether the interval between the neurologic index event and CEA has any clinical effect on periprocedural complication rates.
METHODS
Of 1273 CEAs performed between January 2004 and December 2014, the current study analyzed 401 patients (32%) who underwent surgery for symptomatic 50% to 99% ICA stenosis. The analysis excluded patients with asymptomatic stenosis, those undergoing carotid reconstructions for recurrent stenosis, those with carotid aneurysms, and patients undergoing emergency procedures (Fig 1) . Data were collected based on the obligatory quality assurance assessment for carotid surgery and carotid angioplasty and stenting (CAS) in Germany. We recorded patient demographics, clinical events, vascular or brain imaging results, and surgical procedures. Comorbidities and vascular risk factors were assessed using the valid definitions for the respective year and retrieved from the discharge letters. The study was approved by the Technical University Munich Ethics Committee. Written informed consent was obtained from all patients.
All patients were assessed by a neurologist before surgery and again #24 hours after the procedure. The neurologic index event was classified as amaurosis fugax (AFX), transient ischemic attack (TIA), minor (modified Rankin scale [mRS] 0-2) or major (mRS 3-5) stroke. AFX was defined as partial or complete visual field loss in the ipsilateral eye being completely reversible #24 hours. TIA was defined as ipsilateral hemispheric focal neurologic dysfunction contributing to contralateral neurologic symptoms lasting <24 hours. Retinal ischemia and stroke were defined similarly to AFX and TIA, respectively, but lasting >24 hours.
All patients received antiplatelet therapy before surgery. Statin therapy was used in patients with hyperlipidemia. However, because guidelines changed during the observation period, statin therapy was given to all patients before surgery in the latter years of the study.
Shunting was used if patients treated under locoregional anesthesia showed any neurologic symptoms, if ICA backflow was low, or in patients with an incomplete circle of Willis or contralateral ICA occlusion. Patients' postoperative blood pressure was monitor-controlled for 6 hours and then measured every 2 hours thereafter, targeting a systolic blood pressure of <140 mm Hg.
The primary study end point was the combined perioperative in-hospital rate of any stroke or death. Periprocedural stroke was defined as a new focal neurologic dysfunction or aggravation of more than 1 point on the mRS lasting >24 hours. Secondary end points were the single compounds of the primary end point and noncerebral complications of myocardial infarction, severe (22) 16 (25) 40 (24) .74
Peripheral artery disease 52 (13.0) 10 (17) 24 (22) 1 (2) 17 (10) .0010
Renal insufficiency 27 (6.7) 6 (10) 7 (6) 3 (5) 11 (7) .68 COPD 25 (6.2) 6 (10) 7 (6) 4 (6) 8 (5) .57
Abdominal aortic aneurysm Statistical analysis was by the Fisher exact test for categoric variables and analysis of variance for group medians. c Using the ASA Physical Status Classification system: ASA I: a normal healthy patient; ASA II: a patient with mild systemic disease; ASA III: a patient with severe systemic disease; ASA IV: a patient with severe systemic disease that is a constant threat to life; ASA V: a moribund patient who is not expected to survive without the operation; ASA VI: a declared brain-dead patient whose organs are being removed for donor purposes. wound hematoma, and cranial nerve palsy. Myocardial infarction was defined as a rise in cardiac biomarkers supported by typical clinical symptoms or electrocardiographic changes, or both. Severe wound hematoma was defined as neck bleeding requiring surgical revision. Cranial nerve palsy was specified as a temporary or persistent sensory or motoric neurologic deficit attributable to the surgical field.
The interval (given in days) between the last index neurologic event and the time of the procedure was the main independent variable (predictor). The last neurologic event was defined as the most recent TIA or AFX, or the last neurologic aggravation of a manifest stroke. For better comparability with former studies 8, 10, 11 and guidelines, time intervals were divided into four groups: group I, 0 to 2 days; group II, 3 to 7 days, group III, 8 to 14 days; and group IV, 15 to 180 days.
Statistical data analysis was performed using SPSS Statistics for Windows 23.0 (IBM Corp, Armonk, NY), by way of c 2 tests and multivariable regression analysis adjusting for sex and age. The significance level was set at P < .05.
RESULTS
The included patients (68.1% male) had a median age was 70 years (interquartile range [Q1-Q3], 63-76 years). The neurologic index event was ipsilateral AFX in 25.4%, ipsilateral TIA in 43.4%, and ipsilateral minor and major strokes in 22.7% and 8.5%, respectively. Further patient demographics, comorbidities, and the grade of stenosis are reported in Table I . Between 2004 and 2014, 58.6% of patients received surgery #14 days, with a median interval of 10 days (Q1-Q3, 4-28 days). As illustrated in Fig 2, the interval between the first neurologic consultation and CEA decreased over the years. Overall, time interval between the first consultation with a vascular surgeon to CEA was a median of 3 days (Q1-Q3, 1-6 days) and the median delay between neurologists and vascular surgeons was 0 days (Q1-Q3, 0-3 days).
Before surgery, all patients underwent duplex ultrasound imaging and an additional vascular imaging procedure (magnet resonance angiography in 63.6% and computed tomography angiography in 38.9%). Almost all patients received brain imaging diagnostics before CEA (92.3%), consisting of cranial computed tomography (43.9%) or cranial magnetic resonance tomography (70.3%). Postoperative brain imaging was performed in patients with preoperative major strokes because neurologic aggravation in these patients is difficult to detect. All other patients only received postoperative imaging in the presence of new symptoms or deterioration of their preoperative neurologic status. Concerning the interval between the index event and surgery, 15% of all CEAs were in group I (0-2 days), 27.4% in group II (3-7 days), 16.2% in group III (8-14 days), and 41.4% in group IV (15-180 days) . No significant differences were found between the different time groups in patient age, gender, cardiovascular risk factors, or comorbidities (Table I) . No significant differences were found between the different time groups among patients who sustained an AFX or TIA. Stroke patients were treated significantly more often between 3 and 14 days after the index event (Table I) . Details on surgical procedures are given in the Supplementary Table (online only). Almost all patients were on antiplatelet therapy in the form of aspirin (91.7%), clopidogrel (0.9%), or both (4.1%). Statin therapy was used in 74.1% of all patients and became the standard medical therapy in this patient cohort, together with antiplatelet therapy, in the latter years of the study observation period.
The eversion technique was used for CEA in 60.1%, and the procedure was performed under locoregional anesthesia in 50.1% of patients. Primary or secondary shunting was applied in 28.2%. The differences among the four time interval groups in surgical and anesthetic techniques or in any other perioperative measures were not significant.
The overall in-hospital combined stroke and mortality rate was 2.5% (n ¼ 10), without significant differences during the observed time period (Fig 3) . The separated perioperative mortality and stroke rates were 1.0% and 1.5%, respectively (Table II) . Minor and major strokes each occurred in 0.7% (n ¼ 3). The combined stroke and mortality rate was 3% in group I, 3% in group II, 2% in group III, and 2% in group IV, without any statistically significant differences between the time interval groups in the crude or the gender-adjusted and age-adjusted analyses (Fig 4 and Table II) .
Ipsilateral stroke occurred in six patients. Cerebral bleeding occurred in two of the stroke patients, which was fatal in one patient (Table III) . The combined stroke and mortality risk was 2.0% (n ¼ 2, N ¼ 102) in patients with AFX, 2.2% (n ¼ 4, N ¼ 174) in patients with TIA, 2.2% (n ¼ 2, N ¼ 91) in patients with a minor stroke, and 5.8% (n ¼ 2, N ¼ 34) in patients with a major stroke as the index event (Tables I and III) . Four patients (1%) died between 1 and 10 days after the procedure (Table III) . Severe cerebral complications occurred in two of these patients (brainstem infarct on day 10, intracranial hemorrhage on day 3). Both patients underwent surgery after a major carotid-related stroke on days 1 and 37 after the index event. Two further patients died of noncerebral complications (myocardial infarction on day 1, fulminant pneumonia on day 3).
Myocardial infarction, peripheral nerve lesions (as assessed by the neurologist), and postoperative hematoma with surgical revision occurred in 0.7%, 2.2%, and 1.7%, respectively (Table II) . 
DISCUSSION
This retrospective single-center trial included 401 patients treated for symptomatic carotid stenosis between 2004 and 2014. The overall stroke and mortality rate was 2.5%, and the stroke rate during the first 48 hours after the index event was 3%. Multivariable analysis did not show an influence of the time interval on the perioperative stroke and mortality rate (Fig 4) .
The present results are in accordance with recently published studies (Table IV Although patients who had experienced AFX and TIA were evenly distributed in the different time interval groups, patients who had sustained a stroke more often received surgery in time group II (3-7 days) or group III (8-14 days). This might have been caused by waiting for spontaneous improvement during the first few days. An observational study in the United Kingdom reported Multivariable analysis with adjusted risk ratios (RR, squares) and 95% confidence intervals (CI; horizontal lines) for the combined stroke and mortality risk on a logarithmic scale, adjusted for female vs male sex and age per 10-year increase. that between December 2005 and December 2007, only 20% of patients were treated #2 weeks after the most recent neurologic event. Once they were admitted to the hospital, 94% had CEA #2 days. 15 In the present study, 58.6% of patients received surgery #14 days during the observational period between 2004 and 2014, with a median interval between the last index event and CEA of 10 days (Q1-Q3, 4-28 days). As illustrated in Fig 2, the interval between the first neurologic consultation and CEA decreased over the years. Overall, the median interval between the first consultation with vascular surgeon to CEA of 3 days (Q1-Q3, 1-6 days) and the delay between neurologist and vascular surgeon of 0 days (Q1-Q3, 0-3 days) outlines fast in-hospital management and good interdisciplinary cooperation. Nevertheless, continuing the close collaboration between neurologists, anesthesiologists, and vascular surgeons is important. Regarding the period before admission, the median interval between the neurologic index event and the first consultation with a neurologist was 1 day (Q1-Q3, 0-8.75 days), and this was more or less stable over the years (Fig 2) .
Intracranial hemorrhage was seen in three of the patients who underwent postoperative cranial computed tomography or magnetic resonance. One patient suffered from a headache. Only one of the four patients died of an intracranial hemorrhage, and only one of the six patients suffered a hemorrhagic stroke. Both patients had received surgery late, 70 and 37 days after the last neurologic event, respectively. The risk of hemorrhagic transformation of cerebral infarction caused by early surgery, as has been controversially discussed for decades, is not supported by our findings. 16 The reasons for procedural stroke were analyzed in the ICSS RCT 17 and in the Carotid Revascularization Endarterectomy vs Stenting Trial (CREST) 18 : in patients treated by CEA, strokes were hemorrhagic in 18% (ICSS) and 14% (CREST). Both reports mentioned postoperative hypertension as the most important risk factor for hemorrhagic stroke. In the current population, hemorrhagic strokes represent 25% (n ¼ 2, N ¼ 8) of all strokes, including fatal strokes leading to death. Both patients' blood pressure was monitored postoperatively, targeting a systolic blood pressure of <140 mm Hg. One of the patients was on singleantiplatelet therapy and the other on dual-antiplatelet therapy; therefore, the definitive reason for hemorrhagic strokes in the current cohort remains unclear. The procedural stroke risk is known to be higher in patients treated by CAS. 19 Regarding the timing of carotid revascularization, a pooled analysis of the three RCTs EVA-3S, SPACE, and ICSS showed that patients treated by CAS within the first 7 days had a higher risk of any stroke or death compared with patients treated by CEA (risk ratio of CAS vs CEA, 3.4; 95% confidence interval, 1.01-11.8). 12 Most of the strokes are ischemic, caused by procedural arterial embolism. However, the incidence of hemorrhagic strokes in patients treated by CAS was lower compared with CEA, at only 3% (ICSS) and 8% (CREST). 17, 18 Dual-antiplatelet therapy, used as a standard drug regimen in CAS patients, does not therefore seem to be the most important risk factor for periprocedural hemorrhagic strokes. Although the mortality risk was not significantly different among the time interval groups, three of the four patients who died were operated on #3 days (Table III) . Two patients were American Society of Anesthesiologists (ASA) Physical Status Classification III and one was IV, reflecting a high degree of comorbidity. The three patients died of different causes (brainstem infarction, myocardial infarction, fulminant pneumonia), and the neurologic index events were different in all three. Because of the heterogeneity of these three patients and that they represented only a small group, determining a high-risk subgroup of patients in whom early CEA might have no benefit is not possible.
This study has some limitations. With only 401 patients and 10 outcome events, the main limitation of this single-center study is its small cohort size, thus reducing the assumable statistical power of the analysis for identifying existing events. Furthermore, the performed multivariable analysis could be biased because w10 events per independent variable are recommended to provide good results with this statistic model. 20 To keep the bias low, we only adjusted for the variables of sex and age. Because patients were not randomized according to the time interval, unobserved confounders associated with the time interval might have biased the results. In addition, selection bias may reduce the external validity of the results, because the study was performed in a large university hospital. Therefore, the composition of the patient cohort might differ from the average population in medical or technical demands.
Strengths of the study were the consecutive design including all symptomatic CEAs performed between 2004 and 2014 as well as the complete presurgical and postsurgical neurologic assessment providing reliable information on the neurologic index event and periprocedural strokes.
CONCLUSIONS
We found no evidence for an increased perioperative risk of stroke or mortality when CEA was performed during the early phase after the neurologic index event in patients with a symptomatic 50% to 99% extracranial carotid artery stenosis. In accordance with current guidelines, CEA can be performed as early as possible. 
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